chrisvoncsefalvay/vaers-outcomes huggingface dataset:
breakthrough case of Covid with very mild symptoms / get tested and was positive; breakthrough case of Covid with very mild symptoms / get tested and was positive; bad stomachache; tired; chronic congested nose; This is a spontaneous report from a contactable consumer (Patient) or other non-HCP. A 64-years-old female received second dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date in Mar2021 as dose 2, single for COVID-19 immunization. Also, the patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date in Feb 2021 as dose 1, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date in Sep2021, the patient experienced breakthrough case of COVID with very mild symptoms / get tested and was positive, bad stomach ache, tired and chronic congested nose. It was reported that she had the vaccine in February and March and had a breakthrough case of COVID with very mild symptoms at the beginning of September. She stated, the symptoms she had were a bad stomach ache and went to get tested and was positive. She stated, while she was home quarantining she found she was tired and had a chronic congested nose which she has had numerous times since. She asked when was she eligible for the booster because of the breakthrough case. She stated, she was exposed a lot and wondered if the congestion was the body fighting off the exposure she had. She stated, she talked to someone already who screened her about her breakthrough case. She stated someone told her she needs to wait 90 days after having COVID and she was 60 days from this. The outcome of the events breakthrough case of Covid with very mild symptoms / get tested and was positive, bad stomach ache, tired and chronic congested nose was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Around 12 hours after my shot, I experienced chills and irregular heartbeat for around 30 minutes.
12 hours after vaccine I had a 101 degree temperature that diminished over a 10 hour period.
Day following the injection I had a raised red circle. Three days later I had joint pain in shoulder where transdermal injection was given. Pain not as severe but continues as of this date 11/10/2012.
Patient fainted and fell out of his chair. He hit is head against the wall on his way down.  His sister called us over. The patient I was counselling at the register happened to be a nurse.  She reached him first and assessed him for breathing and heart rate. He was not bleeding. We placed him in the recovery position.  The nurse noticed some firemen in the store and called them over. They did a basic assessment, but not a full write up.  After 10-15 minutes, he  felt well enough to sit up.  He remained seated for another 10-15 minutes.  He said his head hurt and was a 4 on a scale of 1-10. I told the patient's father to monitor his headache and if it gets very bad to seek medical attention.
24 hours post-vaccination, pt developed abdominal pain, dizziness, weakness, frequent diarrhea, myalgias. After 3 days of symptoms, pt was taken to ER by EMS and admitted w diagnosis of colitis, likely ischemic.
our pharmacy had a clinic on 10/12/2022 for a flu clinic where we gave vaccines to whoever the staff told. Patient received the vaccine on 10/12/22 but the staff gave the pharmacy staff paperwork again to give the vaccine to the patient on 11/11/2022. Typically we rely on the staff at the long term care to to give pharmacy paperwork and information that tells us who needs the vaccine and who doesn't. Once the staff at the assisted living told our staff they need the vaccine employee gave the flu shot. We did not know the patient had already gotten it
pt recvd vax & area was hot to touch & tender w/ knot; area slightly pink, size 2.5 inch wide x 3.5 inch long; to er, tx w/ meds;
Headache, slight fever, body chills, slight congestion, slight cough. Started at noon on 5 March 2021 (same day as vaccination). Took OTC Tylenol and NightQuil. Symptoms lasted 48 hours; started feeling better on Sunday (7 March 2021).
1050  Patient states tongue feels swollen, hard time swollowing. 50mg benedryl given.  1105Patient complaining of more difficulty breathing. toes/hands are cold.  Dr called to room. RN  1120 Claritin given.   1130 Pulse ox down to 65; epi 0.3mg given. Dr called to room. O2 brought to room; Titrated up. Pulse ox up to 80 for a minute or two then down to 45. Dr in room. EMS called. IV tray brought in. 20G IV placed in RAC, NS bolus started. Pulse ox up to upper 80's low 90's on 9L 02. with Dr at bedside. 1155 EMS to bedside.
Vaccine given 13 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 13 days post expiry) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 13 days post expiry). On 19-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 13 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.   This case was linked to MOD-2021-395985 (Patient Link).
Complex febrile seizure and rash. 7/6-7/7 Generalized tonic clonic seizures all <1min, 3 in less than 24hrs. Non-specific erythatmous papular rash very localized emerging on 7/7
Patient received her second COVID shot today around 3.40p. She said she had a history of anaphylaxis in the past with an allergy shot she received as well as with Lovenox. I asked the patient to wait 30 minutes after administering the vaccine. After 10 minutes she began having tingling of the lips and some swelling near her cheeks, breathing was fine. I gave 50mg of oral Benadryl to patient at 3:50p. Patient said she felt as if her tongue was beginning to swell and her cheeks were getting more swollen. She said her symptoms resembled what happened with her first anaphylaxis response and that it also was very gradual. Patient was awake and alert and could breathe normally so no reason to administer Epipen but called EMS due to patient saying her tongue was swelling more and could feel her throat getting narrower. EMS arrived and accessed the patient. I told them about her condition and the dose of Benadryl that I gave. They checked her blood pressure, heart rate, looked at her tongue and accessed her breathing and said she is okay and no need to be taken to hospital unless patient wanted to be taken. Patient agreed not to go and signed a refusal form by EMS. EMS told her she was fine to go home and patient was fine and bought liquid Benadryl to take with her and went home.
The first night I had to sore arm and cold chills with a fever. By the third day I noticed that I was having hair loss. By day 7 I had lost a lot of hair to the point I cut 5 in off thinking it would help. I have contacted the pharmacy called the CDC number and I have a doctor's appointment to have labs done. I am now saving my hair and I have a 1 gallon Ziploc bag full as well as photos. My hair has thinned out tremendously and is still falling out almost one full month after the initial shot. I was notified by the CDC number that I contacted not to get the second shot due to this reaction.
This non-serious consumer report (initial receipt 17-Oct-2014) concerns a female patient. On an unspecified date, the patient received the flu shot (manufacturer and batch number not reported) and ZOSTAVAX injection (batch number not reported) one shot for vaccination. On the unspecified date in 2014 (earlier this week), the patient developed an injection site reaction that included swelling, redness and itchiness 48 hours after receiving the ZOSTAVAX. Within 24 hours of receiving the flu shot, the patient developed flu-like symptoms. Outcome was not reported.
Rash all over body, itching, difficulty breathing, Atarax 25 mg PO x 1
Felt nauseous and dizzy, then developed episode of syncope.  Pt has a history of vasovagal syncope to certain situations and this was most likely vasovagal. All symptoms resolved later that day.
I had my 1st shot Jan-2020 and due to Covid restrictions I have not had my 2nd shot.; This case was reported by a consumer via interactive digital media and described the occurrence of social problem in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included shingles vaccine (received 1st dose on an unknown date in January 2020).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.   Additional Information: GSK Receipt Date: 13-MAY-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The patient received first shot in January 2020 and then due to Covid restrictions he/ she was not received second shot. The reporter asked Should he/ she start over with the first shot as it was over two years. Additional Supportive Information: Follow up would not be possible since no contact details provided.
Pain/swelling at injection site.  Extreme muscle and joint pain. Slight fever for about 6 hours early 7/27. Chest pains-felt heavy. No problem breathing though. Extreme fatigue, chills, and overall discomfort. This happened for 2 days. Went back to work on the 29th with mild fatigue, experienced tons of workplace stress and by end of day completely had all symptoms except the fever back.  7/30 went to  urgent care and they determined my immune system wasn?t bouncing back like it should be. They gave me a steroid shot and sent off a Covid test. By 8/2 I was pretty good. 8/2 - 8/5 just had fatigue by end of day. After 8/5, I was good to go.
This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received first dose of PREVNAR 13, via an unspecified route of administration in the arm on 29Aug2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On 04Sep2018, the patient reported that she noticed hives in her arm in the area of the vaccine. The outcome of the event was unknown. Information on the batch number has been requested.
This patient complained about arms hurting and getting hot. He then had multiple episodes of vomiting. The patient got very pale with staring, and his heart rate increased. He then became limp and lifeless and eyes rolled back. This lasted for about two minutes. While hurrying to the ER, the patient went into a seizure and the mother even thought he had died.  The ER doctor said it was probably a reaction the the shots.
Fever and chills onset 7pm 24 hours after Injection. Saturday morning woke up and hearing was affected all sounds were heard as digital.  Ringing in ears was significant and overal fatigue. Monday following the vaccine ? extreme vertigo and dizziness and eye sight affected with inability to transfer from looking at one object to another. Objects appeared to be flickering and vertigo persists
after getting the first dose it returned to the state it was when she had labored breathing due to covid,; her mom had gotten covid and she was exposed to her; This is a spontaneous report from a contactable consumer (patient herself). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection lot number: unknown, expiry date: unknown) via unspecified route of administration on 21Jul2021 as dose 1, single for covid-19 immunisation. Concomitant medications were not reported. Patients medical history included covid-19 on an unspecified date in Jan2021 (she got sick from having covid and she had labored breathing, but it was not enough to want to be hospitalized). Since then her breathing had been labored but seemed to be getting better. However after getting the first dose it returned to the state it was when she had labored breathing due to covid, not to the point where she couldnt breathe at all but she was worried after the second dose how it would affect her. Was it something she needed to be concerned with, was this common, was it safe to take the second dose, and what was the proper avenue to make sure it is safe to take the second dose. She would like medical guidance on dealing with the covid vaccine. She doesn't have a primary care provider. She generally go to # since they are far and few between for a cough or something but it costs a fortune. She was supposed to get the second dose on 23Jul2021 however, her mom had gotten covid and she was exposed to her. She declined to complete a safety report on behalf of her mother. No further details provided. She was exposed to her and she tested negative. Then she tested negative when she got a second test. She was supposed to get the second dose by Friday and is trying to get medically situated. She was supposed to get it on the 23Jul2021 but for the second dose is says she could not be exposed to covid. The reason she was trying to figure out if she could proceed with it over the next 14 days and who was supposed to guide her. Yes it was safe or no to not get it.   Follow-up attempts have been completed. Batch/lot number not available for BNT162B2. No further information is expected.
Received Booster of Pfizer at hospital. Vaccine event on 02/09/2022, on next day 02/10/2022, side effects developed as in "It feels rather bruised and I get shooting pain down my arm."  she been having stiff muscles on my shoulder and neck on the side of the injection left arm, as well redness, sore swollen knot of injection site. Took Tylenol that on 10th to help alleviate pain along with warm compress. Still is having some swelling and redness, soreness, stiffness of left upper arm area. Wanted to go to urgent care but didn?t seek care, has made an appointment with PCP in few day as well seen sport physical therapist to work on it .All above has been done and she is still in continuous pain.
Patient received an expired vaccine; received an expired vaccine past 30 days in the fridge; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED DEVICE USED (Patient received an expired vaccine) and PRODUCT STORAGE ERROR (received an expired vaccine past 30 days in the fridge) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED DEVICE USED (Patient received an expired vaccine) and PRODUCT STORAGE ERROR (received an expired vaccine past 30 days in the fridge). At the time of the report, EXPIRED DEVICE USED (Patient received an expired vaccine) and PRODUCT STORAGE ERROR (received an expired vaccine past 30 days in the fridge) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported.  No treatment information was reported.
vial left in fridge and was not thrown out after 30 day beyond use date; Dose administered after 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date) and PRODUCT STORAGE ERROR (vial left in fridge and was not thrown out after 30 day beyond use date) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 048L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial left in fridge and was not thrown out after 30 day beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date) and PRODUCT STORAGE ERROR (vial left in fridge and was not thrown out after 30 day beyond use date) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.  It was reported that the vial was initially stored in refrigerator on 22-Mar-2022.  The vial did not undergo any temperature excursion. It was also reported that the vials were un-opened but administered to 7 patients 11 days after the beyond use date on different dates of 3 doses administered on 28-Apr-2022, 1 dose administered on 03-May-2022 and 3 doses were administered on 05-May-2022.   This case was linked to MOD-2022-577179, MOD-2022-577174 (Patient Link).
I had vaccination 02/2022. In 03/2022 I started to have a fever aches and fatigue and I tested COVID-19 positive. I still have brain fog but I am uncertain if it is from COVID-19. I had really bad chest pain after having COVID-19. I was informed that it could be inflammation around the heart. I took anti inflammation medication and it helped the symptoms.
This spontaneous case was reported by a consumer and describes the occurrence of CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ASTHMA (Asthma) and DYSPNOEA (Difficulty breathing which started in the morning and got worst by evening / Barely catch his breath) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heavy smoker in 2020.   On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 03-May-2021, the patient experienced PRURITUS (Feeling scratchy). On 04-May-2021, the patient experienced CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) (seriousness criterion medically significant), ASTHMA (Asthma) (seriousness criterion medically significant), DYSPNOEA (Difficulty breathing which started in the morning and got worst by evening / Barely catch his breath) (seriousness criterion medically significant) and WHEEZING (Wheezing sounds). On 02-May-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. On 03-May-2021, PRURITUS (Feeling scratchy) had resolved. On 06-May-2021, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ASTHMA (Asthma), DYSPNOEA (Difficulty breathing which started in the morning and got worst by evening / Barely catch his breath) and WHEEZING (Wheezing sounds) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2021, Oxygen saturation: 91 Low.         On 03-May-2021, the patient was feeling scratchy and mentioned it could be due to pollen. On 04-May-2021, he was experiencing difficulty breathing, which began in the morning and exacerbated by the evening. He had wheezing sound and by 6 PM he could barely catch his breath. He got breathing treatment using nebulizer and his oxygen level was 91. By 8 PM he went to the ER  and underwent tests. He was diagnosed to have Asthma and COPD.  Treatment: Inhaler, nebulizer and steroid.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient experienced a maculopapular exathem similar to measles 1 week after vaccination
breathing difficulties/shortness of breath that worsens with any activity; soreness/body aches; slight fever; intense headache; Dry cough; feel dizzy; This is a spontaneous report from a contactable consumer (the patient). A 40-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) via an unspecified route of administration in left arm on 12May2021 13:45 at age of 40-year-old at single dose for COVID-19 immunisation. Medical history included ongoing asthma, chronic migraine, known allergies: sulfa drugs, COVID-19 in Mar2020 (COVID test positive in Mar2021, confirmed by antibodies in May2020). Concomitant medications included nortriptyline, tizanidine, propranolol (PROPANOLOL) and zolpidem (ZOLPIDEM), all taken for an unspecified indication from an unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in left arm on 21Apr2021 13:45 at age of 40-year-old for COVID-19 immunisation. The patient had injection site pain with the first dose that cleared within a day. The second dose was when things became complicated. She had soreness, body aches, slight fever, and an intense headache as expected, but also, she experienced the same breathing difficulties she had when she had COVID. Dry cough and shortness of breath that worsens with any activity. She had preexisting asthma. It is not as bad as the shortness of breath she had with COVID, but it was similar (and different than her asthma symptoms - she didn't feel chest tightness, but she feel dizzy as if she was not getting oxygen when she move). She hadn't seen her primary care provider because it's not so bad that she needs medical attention, but she did want to report the adverse event since it's not a symptom she was warned about. The events onset date was reported as 13May2021 16:00. Treatment for the event (breathing difficulties/shortness of breath that worsens with any activity) included used albuterol rescue inhaler. The patient had not test COVID post vaccination. The outcome of the events was not recovered. The report considered non-serious.   Information on lot/batch number has been requested.